From
the Desk of Ernest A. Carabillo , Jr.
Conference
Chairman
Founder, ExperTech Associates
Dear
Colleague:
Have you
noticed that the warning letters delivered recently
to medical device firms from the FDA have included
statements like:
“Your
firm’s internal audits failed to verify that the
quality systems…”
“Your
firm’s management with executive responsibility
failed to review the suitability and effectiveness
of the quality system…”
“Your
firm failed to establish and maintain adequate
procedures for implementing corrective and
preventative action…”
“Your
firm failed to validate computer software…”
With years of
experience in the medical device industry I can tell
you that there are preferred techniques for
addressing FDA inquiries and observations. There
is good advice available on how to think
strategically about CAPA, software validation, risk
management, internal audits, and how to field an
inspection.
The Second
Annual Medical Device Quality Congress, being held
April 5-7, 2005 in San Diego, California, is an
opportunity for you to get the information you need
on these important topics. It is my pleasure to
invite you to attend and gain the latest thinking
from what I’d call a “powerhouse” of conference
speakers.
Keynote
speeches will be given by Timothy Ulatowski,
Director, Office of Compliance, Center for Devices
and Radiological Health, U.S. FDA and Julio Rivera,
Director of Corporate Compliance, Medrad, Inc.
Medrad is a 2003 Malcolm Baldridge Quality Award
Winner.
Other notable
experts round out the conference faculty, including:
Mark Brown,
Partner, King & Spalding LLP
- Former
Associate Chief Counsel for Enforcement in the
Office of General Counsel for the FDA
Russ Davies,
Vice President, Regulatory Affairs and Quality
Systems, Smiths Medical -
Russ has provided a leadership role in
implementing several quality management systems to
meet European and US regulatory requirements within
medical device companies.
Charma Konnor,
Senior Manager/Consultant, Devices and Drugs,
Phoenix Regulatory Associates, LTD
- Directed regulatory and compliance
issues for 25 years at the FDA.
John Malloy,
John Malloy and Associates -
Internationally recognized expert
consultant formerly with FDA
Maarten
Meuhlenbelt, Partner, NautaDutilh, Brussels, Belgium
- Maarten has
extensive litigation experience in the EC
Commission. He is recommended in European Counsel's
Life Sciences Industry Report.
Armin Torres,
Certified Software Quality Engineer, Qualified Data
Systems, A Division of BioTeknica
- Armin held responsibility for Total
Quality Management of in-process quality control
inspection, test, and engineering for coronary
pacemaker manufacturer and has developed process
validation standards and training programs.
We are all
prepared to deliver up-to-date, quality and
regulatory intelligence. Please join with me and
your peers in industry to share expertise and
experiences, to discuss approaches that can be put
into practice immediately, and to return to our
organizations with the latest news affecting our
industry.
Best Regards,
Ernest
Carabillo
Conference Chairman |